Pericolonic tumor deposits (PTDs) 
Colorectal carcinoma is the third most common malignancy in the world. The incidence and mortality of that tumor in the United States during 2007 were 50.6 and 18.8 per 100,000, respectively. 1 Prognosis estimation and therapy stratification are traditionally based on the American Joint Committee on Cancer (AJCC) paradigm for staging, using data regarding the primary tumor, regional lymph nodes, and distant metastasis (TNM) system. In that model, pericolonic tumor deposits (PTDs) are defined as tumor nodules in the surrounding pericolonic/perirectal adipose tissue outside lymph nodes. 2 Patients with PTDs have an adverse prognosis, and their disease-free survival is significantly lower compared with patients without such deposits. 2, 3 Therefore, PTDs were included in TNM staging for the first time in 1997. PTDs were defined therein as isolated tumor deposits, with the recommendation to classify nodules larger than 3 mm as lymph node metastases. The definition and rule were changed in the next edition of the AJCC handbook in 2002 and might be changed again in the forthcoming version. PTDs are currently classified as nodal implants (N1) if they have the round and smooth contour of lymph nodes and as venous infiltration (V1/V2) if they have an irregular, polycyclic shape. However, that recommendation has been criticized because it is not well supported by published data. 4, 5 Hence, disagreement exists about the correct classification of pericolonic tumor deposits. In contrast with the current TNM system, Puppa et al 6, 7 propose classifying PTDs as pM1a (PTDs without lymphocytes and association with veins or nerves), whereas pM1b is reserved for the classification of distant metastases. Ueno et al 8 classified PTDs as vascular invasion type and non-vascular invasion type. Some authors suggest reporting the number and the diameter of PTDs separately in the pathology report in addition to true lymph node metastases. 2 The objectives of our study were to perform a systematic histomorphologic study to investigate the origin of PTDs and to answer the question of whether it is reasonable to classify PTDs according to their shape. Therefore, we step-sectioned the complete tumor regions of advanced colorectal adenocarcinomas and evaluated their histomorphologic features with emphasis on the occurrence and distribution of PTDs and their association with anatomic structures.
Materials and Methods
Fresh and unopened colorectal specimens were directly brought to the department of pathology at the Klinikum Augsburg, Augsburg, Germany, after surgical intervention. Neoadjuvant radiochemotherapy was an exclusion criterion. A total of 21 cases were evaluated for this study. The specimens were opened and washed, and intra-arterial methylene blue injection was performed as described previously 9 to ensure an optimal lymph node harvest. The resections were fixed overnight in 10% buffered formalin. The next day, the specimens were macroscopically evaluated. In advanced cases with macroscopically evident infiltration of pericolic or perirectal fat, the whole tumor region, including the surrounding adipose tissue, was completely sectioned in 5-mm thin slices. Then the slices were oriented and embedded in large paraffin blocs. Whole-mount sections (2-4 μm) of the tumor regions were cut, and all slides were stained with H&E for histologic assessment. The slides were then screened for the occurrence of PTDs.
In this study, PTDs were defined as tumor nodules isolated from the main tumor without preserved lymph node or vascular or neural structure. This primary screening is the standard method of determining the presence of PTDs. Clear intravascular invasions were classified as V1 or L1. All 7 cases with identified PTDs were subsequently step-sectioned, resulting in a total of 692 slides, which were H&E stained and systematically screened by 1 pathologist (K.W.) ❚Figure 1❚. All PTD+ cases were additionally evaluated by a second pathologist (B.M.). In discrepant cases, consensus was found after discussion. Slides "suspicious" for vascular invasion were destained and afterward restained with elastic van Gieson to confirm or exclude the vascular nature of the structure.
Based on information obtained from the step sectioning, the origin of each PTD was determined to be 1 of 5 options: a "free PTD," in which there was no association with anatomic structures and the origin was unclear; "continuous growth," which showed a connection to the main tumor in subsequent sections (not a true PTD); and, depending on structures found associated with the PTD, "venous vessel," "lymphatic vessel," or "nerve sheath."
The shapes of the PTDs were differentiated into 2 categories, polycyclic and oval-round. Deposits were also categorized into nodules 3 mm or smaller and more than 3 mm in largest diameter. Only the neoplastic glands and clusters were measured; the surrounding desmoplastic stroma was excluded from the measurement.
We also divided the colorectal adipose tissue into 3 regions: inner, middle, and outer thirds and classified all PTDs depending on their zonal distribution ❚Image 1❚. A total number of 69 pericolonic tumor deposits was found. The mean number of deposits was 10 (range, 1-18). Of 69 deposits, 34 (49%) were classified as free PTDs because no association with anatomic structures could be identified; 7 (21%) of 34 were oval-round, and 27 (79%) had a polycyclic shape. Of the 69 PTDs, 8 (12%) showed continuous growth from the tumor; 3 (38%) were oval-round, and 5 (63%) were polycyclic. Association with venous invasions was found in 18 (26%) of 69 PTDs, 4 (22%) oval-round and 14 (78%) polycyclic. Lymphatic vessel association was found in 3 PTDs (4%), 1 (33%) oval-round and 2 (67%) polycyclic. A relation to nerve sheaths was found in 6 PTDs (9%), 1 (17%) oval-round and 5 (83%) polycyclic ❚Figure 2❚. No statistically significant correlation between the shape and the origin of PTDs (P = 1.0) was found. Except for perineural infiltrations, all other morphologic features showed a balanced distribution of small (≤3 mm) and larger (>3 mm) lesions ❚Figure 3❚.
One case showed all 5 PTD origin sources. In 2 cases, 3 and 4 different origin sources were found. Besides tumor involvement of a single vein, one case showed only free PTDs. In another case, a single PTD was identified, which was identified as intravenous. At least 1 of the identified PTDs proved to be vascular invasion in each case.
All 8 PTDs with continuous growth were found within the inner third of the pericolonic-perirectal adipose tissue. The so-called free PTDs and PTDs with association with venous vessels were found in all 3 areas. PTDs that were determined to be associated with lymphatic vessels or nerve sheaths were found only in the inner and middle thirds of the adipose tissue ❚Table 2❚. Within the outer third, besides free PTDs, only venous infiltrations were found.
The association between shape and origin of the PTDs was calculated by using the Fisher exact test. A P value of less than .05 was considered significant. The analysis was performed with SigmaStat 3.5 software (Systat Software, Richmond, CA).
Results
PTDs were found in 7 (33%) of 21 cases. Of 16 colon specimens, 2 showed PTDs (13%). The frequency of tumor deposits was much higher within the selected rectal specimens, with 5 (71%) of 7 cases positive. The clinical data for these cases are given in ❚Table 1❚. The typically indicated neoadjuvant radiochemotherapy in the rectal cancer cases was not administered in 2 cases because of active bleeding and in 1 case because of a palliative situation. One patient refused neoadjuvant therapy, and in the other 2 patients, T2 stage was expected based on computed tomography scan or ultrasonic investigation. Distant metastases occurred in 4 of 7 cases with PTDs compared with 2 metastatic tumors in 14 cases in the non-PTD group (P = .120) ( Table 1 ). All metastatic deposit-positive tumors were associated with peritoneal carcinomatosis ❚Table 3❚. This was not found in the 2 cases of the other group.
Discussion
The occurrence of discontinuous tumor nodules in adjacent adipose tissue is a well-known feature of colorectal cancer, first described by Gabriel et al 10 in 1935. Many terms for this phenomenon, such as extramural cancer deposits, mesorectal microfoci, mesenteric tumor nodules, skipped cancer infiltration, and micrometastases, have been used in the literature. 8, [11] [12] [13] [14] Definitions for them also have differed. Goldstein and Turner, 2 for example, define PTDs as palpable lesions, grossly similar to lymph nodes. However, the current TNM classification divides them into microscopic and macroscopic lesions. 15 Despite these nonuniform definitions and the confusing nomenclature, it seems clear that PTDs have a major role in the prognosis of colorectal carcinoma.
The ability of tumors to induce discontinuous deposits, particularly in the area of circumferential resection margins, is thought to be at least one reason for incomplete tumor resection 14, 16 and is the rationale for performing total mesorectal excision in rectal cancer cases. 17 Moreover, the occurrence of tumor deposits is clearly associated with an adverse prognosis, for both colon and rectal carcinomas. In reviewing 12 studies with a total case number of 3,714 patients, Nagtegaal and Quirke 5 found a hazard ratio of 1.96 (95% confidence interval, 1.6-2.6) for disease-free and overall survival in PTD+ cases. The independence from conventional prognostic factors was shown by Harrison et al, 3 Goldstein and Turner, 2 Ratto et al, 11 Ueno et al, 8 and Puppa et al. 6 Since 1997, 2 attempts have been made to include this important histopathologic feature in the TNM classification. The 5th edition of the AJCC manual 18 introduced the so-called 3-mm rule, which assigned nodules smaller than 3 mm as pT3 implants and larger nodules as lymph node metastases. This rule was dropped with the publication of the 6th edition, 15 in which PTDs are classified depending on their shape and size as lymph node metastases or intravascular implants (V1/V2). Objective evidence to support such a scheme is lacking, and it has therefore been criticized. 4, 5 We performed an extensive histomorphologic study using a whole-mount step-section technique to investigate the origin of PTDs and to answer the question of whether it is reasonable to classify PTDs depending on their shape. In this study, in contrast with those performed by Ratto et al, 11 Ueno et al, 8 Ueno and Mochizuki, 12 Wang et al, 14 and Tateishi et al, 19 we did not classify clear intraluminal vascular invasion as PTDs but primarily as venous or lymphatic implants (V1 or L1). This is the most likely reason for finding a relatively low rate of PTD+ cases in colon carcinoma specimens (13%). This is lower than the range of 17.6% to 25.5% reported in the literature. 5 However, one has to keep in mind that we did not include vascular invasion as a form of PTD. The rate of positive cases in rectal specimens was 83%. This can be explained by a selection bias caused by the low number of cases that was studied and the inclusion criteria for advanced cases which had not received neoadjuvant treatment. This constellation of findings primarily applies to rectal carcinomas being subjected to palliative treatment only.
It was necessary to exclude neoadjuvantly treated patients because residual mesorectal tumor implants in these cases are, at least in part, a consequence of the therapy. In our study, we used step sectioning in combination with elastic van Gieson staining to evaluate the origin of the lesions found. We did not perform immunohistochemical investigation because this is technically problematic on whole-mount sections. Moreover, immunohistochemical studies for the detection of vascular invasion are generally unnecessary. 20, 21 Our investigations revealed venous invasion, lymphatic invasion, nerve sheath infiltration, and continuous growth in 26%, 4%, 9%, and 12%, respectively, as the origin of the PTDs. In 49% of the PTDs, no morphologically distinct structure was identified in association with the deposits. In 5 of 7 cases, there was a pattern of 3 or more different origins. The only previous study that used step-sectioning techniques to elucidate the origin of PTDs is that by Goldstein and Turner. 2 However, in their analysis only palpable lesions were included, which were primarily expected to be lymph nodes. Rectal cancers and stage IV tumors were excluded. They found in 10% of PTDs that perineural or perivascular invasion was the source. All other cases showed a combination pattern, and, in 37% of PTDs, perineural, perivascular, and intravascular invasion were seen concurrently. In 51% of PTDs in our study, a single source could be identified ❚Image 2❚; in the other so-called free PTDs the origin remained unclear. A combination of different sources was found in all but 1 case (6/7 [86%]; Table  3 ). Ratto et al 11 investigated only rectal cancer specimens and did not perform step serial sectioning but also embedded the whole tumor regions. Concerning their origin, the neoplastic foci were divided into endovascular, endolymphatic, perineural, and isolated foci. A combination of these sources was found in 41.2% of so-called FOCI+ cases.
Not surprisingly, an analysis of zonal distribution revealed that continuous growth is found solely within the inner third of the surrounding adipose tissue. None of the PTDs identified in the outer third were of lymphatic or perineural origin.
As shown in Figure 2 , round to oval and polycyclic contours were found in all 5 categories, regarding PTD origins. There was no statistical association between shape and origin (P = 1.0). To our knowledge, no other evaluation has addressed this question. The contour of the deposits had no influence on patient outcomes in the study by Ueno et al. 8 From a practical viewpoint, one might be justified in classifying all cases with PTDs as V1 because in each of our cases, at least 1 deposit was determined to be intravenous. On the other hand, it seems questionable whether this would actually describe the nature of these lesions correctly. In their recently published study, Ueno et al 8 divided extranodal cancer deposits (EX) into vascular (VAS) and nonvascular invasion types. A subgroup of VAS was termed aggressive EX. VAS showed a lower hazard ratio compared with the other groups, with hazard ratios of 2.5, 4.7, and 8.0, respectively. This indicates, in our opinion, that PTDs are associated with an even worse clinical course than conventional angioinvasion or lymphangitic carcinomatosis.
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E, A round deposit with lymphocytes was found to be a lymphatic invasion in F (E, H&E, ×150; F, H&E, ×150). G, A polycyclic deposit with lymphocytes and perineural association (H) (G, H&E, ×150; H, H&E, ×150).
Puppa et al 6 also reported vascular lesions separately. They found PTDs to be independently prognostic in colorectal cancer, whereas intramural and extramural venous invasion were not. From their results, they suggested that PTDs represent a special type of destructive venous invasion different from other types of vessel involvement. The aggressive nature of these lesions and the similarity to in-transit metastases in melanoma led them to suggest that PTDs should be considered in the M subcategory of the AJCC model, as long as no surrounding lymphocytes or involved vessels or nerves are found. Accordingly, a proposed subcategory pM1a was given for such lesions in another article by Puppa et al. 7 This definition corresponds to the lesions we termed "free PTDs." Other types of PTDs are to be included in the T and N subcategories of the AJCC scheme.
Another finding that indicates the special nature of PTDs is their close association with peritoneal metastases. That relationship was seen by Goldstein and Turner 2 and also observed in our study (Table 3) . By applying the recommendations of Puppa et al, 7 stage-migration from stage III to IV would have occurred in 2 cases in our study group (case 1 and 2). Case 5 showed an association with a vein on consecutive sections and would, therefore, remain stage III. Given the aggressive nature of PTDs, which has been highlighted in many studies and summarized by Nagtegaal and Quirke, 5 we believe this classification to be superior compared with the current recommendation of the International Union Against Cancer. 15 Finally, the results of our study do not support conclusions concerning the origin of PTDs based only on shape or size of the deposits. Furthermore, tumor nodules that communicate with the primary mass but protrude through the bowel wall should not be included as PTDs. In roughly 50% of cases extensive pathologic analysis can reveal the true origin and classification of PTDs. Examples in which the origin remains unclear should be included in the M subcategory, as proposed by Puppa et al. 7 
